Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells
Authors
Keywords
T cells, Mouse models, Cancer treatment, Colorectal cancer, Animal sociality, Lysis (medicine), Antibodies, Cytotoxic T cells
Journal
PLoS One
Volume 5, Issue 10, Pages e13474
Publisher
Public Library of Science (PLoS)
Online
2010-10-19
DOI
10.1371/journal.pone.0013474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Cancer Stem Cells: Controversial or Just Misunderstood?
- (2009) Craig T. Jordan Cell Stem Cell
- Mode of cytotoxic action of T cell-engaging BiTE antibody MT110
- (2009) Cornelia Haas et al. IMMUNOBIOLOGY
- Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release
- (2009) Maria Amann et al. JOURNAL OF IMMUNOTHERAPY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype
- (2009) Bárbara González et al. STEM CELLS
- Expression of Epithelial Cell Adhesion Molecule in Gallbladder Carcinoma and Its Correlation With Clinicopathologic Variables
- (2008) Sagit Prince et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans
- (2008) Maria Amann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3
- (2008) M. Amann et al. CANCER RESEARCH
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
- PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab
- (2008) M. Jhawer et al. CANCER RESEARCH
- Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
- (2008) Volker Heinemann et al. CANCER TREATMENT REVIEWS
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
- (2008) David J. Wong et al. Cell Stem Cell
- Cancer: Inappropriate Expression of Stem Cell Programs?
- (2008) Yingzi Wang et al. Cell Stem Cell
- CD44 and EpCAM: Cancer-Initiating Cell Markers
- (2008) Rachid Marhaba et al. CURRENT MOLECULAR MEDICINE
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
- (2008) Scott J. Dylla et al. PLoS One
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- EpCAM expression in normal, non-pathological tissues
- (2007) Eva Schmelzer Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More